COALITION GOVERNMENT ANNOUNCES CCSVI POLlCY POSITION - AUSTRALIA
Jul 1, 2016 — The Coalition acknowledges the importance of cardiovascular risk factors to multiple sclerosis (MS). The Coalition maintains a Medicare schedule which supports patients to access essential medical services, including angioplasty.
Medicare benefits are claimable to clinically relevant services. A clinically relevant service is one which is generally accepted by the relevant profession as necessary for the appropriate treatment of the patient.
The Coalition is committed to supporting Australians with MS through access to medicines and research into new treatments. We believe Australian patients should have timely access to innovative new treatments that have been independently assessed as safe, effective and cost-effective.
The Medical Research Future Fund will inject $400 million over the next few years rising to $1 billion once fully established. It provides the opportunity to strategically fund research and address national priorities in a more cohesive and coordinated way than previous approaches. It will complement existing health and medical research funding to improve health outcomes by distributing new funding in more diverse ways to support stronger partnerships between researchers, health care professionals, governments and the community.
The eminent members of the Australian Medical Research Advisory Board, appointed in April 2016, will set out the strategies and priorities to inform decisions made by a re-elected Turnbull Government.
In developing these priorities, the Board http://www.msnetwork.org/future/research-advisory-board.htm
• The burden of disease on the Australian community;
• How to maximise the practical benefits from medical research to as many Australians as possible, and
• How to ensure that funding under the MRFF complements and enhances other financial assistance provided for medical research.
National Campaign Director
29 June 2016